| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95caab0794f3679c2ff4d427e0dc579b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F5-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F5-41 |
| filingDate |
1996-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1997-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2748658-A1 |
| titleOfInvention |
USE OF "ALPHA-BLOCKING" COMPOUNDS, IN PARTICULAR MOXISYLYTE AND / OR DERIVATIVES THEREOF, FOR THE TREATMENT OF ERECTILE DYSFUNCTIONS BY TRANSMUCOSAL BALAN |
| abstract |
The invention relates to the use of one or more compound (s) acting for the treatment of erectile dysfunctions, in particular alpha-blocking compounds, for obtaining a medicament intended for the treatment by the balanic transmucosal route of said dysfunctions in mammals, more particularly in humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9966870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7087240-B1 |
| priorityDate |
1996-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |